SE9802836L - Läkemedel för behandling av schizofreni - Google Patents

Läkemedel för behandling av schizofreni

Info

Publication number
SE9802836L
SE9802836L SE9802836A SE9802836A SE9802836L SE 9802836 L SE9802836 L SE 9802836L SE 9802836 A SE9802836 A SE 9802836A SE 9802836 A SE9802836 A SE 9802836A SE 9802836 L SE9802836 L SE 9802836L
Authority
SE
Sweden
Prior art keywords
schizophrenia
treatment
medicines
analogues
substance
Prior art date
Application number
SE9802836A
Other languages
English (en)
Other versions
SE514606C2 (sv
SE9802836D0 (sv
Inventor
Tomas Eriksson
Original Assignee
Laekartjaenster I Vaestsverige
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laekartjaenster I Vaestsverige filed Critical Laekartjaenster I Vaestsverige
Priority to SE9802836A priority Critical patent/SE514606C2/sv
Publication of SE9802836D0 publication Critical patent/SE9802836D0/sv
Priority to US09/786,149 priority patent/US6468973B1/en
Priority to PCT/SE1999/001441 priority patent/WO2000012115A1/en
Priority to AU58904/99A priority patent/AU5890499A/en
Priority to EP99946505A priority patent/EP1115415B1/en
Priority to DE69915849T priority patent/DE69915849D1/de
Priority to AT99946505T priority patent/ATE262343T1/de
Publication of SE9802836L publication Critical patent/SE9802836L/sv
Publication of SE514606C2 publication Critical patent/SE514606C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Soundproofing, Sound Blocking, And Sound Damping (AREA)
  • Networks Using Active Elements (AREA)
SE9802836A 1998-08-26 1998-08-26 Läkemedel innehållande GnRH-analoger för behandling av schizofreni SE514606C2 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9802836A SE514606C2 (sv) 1998-08-26 1998-08-26 Läkemedel innehållande GnRH-analoger för behandling av schizofreni
US09/786,149 US6468973B1 (en) 1998-08-26 1999-08-25 Method in the treatment of schizophrenia
PCT/SE1999/001441 WO2000012115A1 (en) 1998-08-26 1999-08-25 Use of composition in the treatment of schizophrenia
AU58904/99A AU5890499A (en) 1998-08-26 1999-08-25 Use of composition in the treatment of schizophrenia
EP99946505A EP1115415B1 (en) 1998-08-26 1999-08-25 Use of gnrh analogues in the treatment of schizophrenia
DE69915849T DE69915849D1 (de) 1998-08-26 1999-08-25 Verwendung von gnrh analogen zur behandlung von schizophrenie
AT99946505T ATE262343T1 (de) 1998-08-26 1999-08-25 Verwendung von gnrh analogen zur behandlung von schizophrenie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802836A SE514606C2 (sv) 1998-08-26 1998-08-26 Läkemedel innehållande GnRH-analoger för behandling av schizofreni

Publications (3)

Publication Number Publication Date
SE9802836D0 SE9802836D0 (sv) 1998-08-26
SE9802836L true SE9802836L (sv) 2000-02-27
SE514606C2 SE514606C2 (sv) 2001-03-19

Family

ID=20412345

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802836A SE514606C2 (sv) 1998-08-26 1998-08-26 Läkemedel innehållande GnRH-analoger för behandling av schizofreni

Country Status (7)

Country Link
US (1) US6468973B1 (sv)
EP (1) EP1115415B1 (sv)
AT (1) ATE262343T1 (sv)
AU (1) AU5890499A (sv)
DE (1) DE69915849D1 (sv)
SE (1) SE514606C2 (sv)
WO (1) WO2000012115A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802438L (sv) * 1998-07-07 1999-07-19 Laekartjaenster I Vaestsverige Användning av komposition omfattande minst ett ämne inom gruppen GnRH-analoger för framställning av ett läkemedel för behandling av tvångstanke-tvångshandlingssjukdom
IL147138A0 (en) 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474813A (en) * 1980-10-24 1984-10-02 Schering Corporation Pharmaceutical preparations comprising flutamide
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
FR2661180B1 (fr) * 1990-04-23 1995-04-28 Inst Nat Sante Rech Med (hydroxyproline 9) lhrh, son procede d'obtention et application comme medicament.
RU2091390C1 (ru) * 1995-02-28 1997-09-27 Научно-исследовательский институт фармакологии РАН Замещенные пролилтирозины, обладающие психотропной активностью

Also Published As

Publication number Publication date
EP1115415A1 (en) 2001-07-18
SE514606C2 (sv) 2001-03-19
US6468973B1 (en) 2002-10-22
WO2000012115A1 (en) 2000-03-09
EP1115415B1 (en) 2004-03-24
ATE262343T1 (de) 2004-04-15
SE9802836D0 (sv) 1998-08-26
DE69915849D1 (de) 2004-04-29
AU5890499A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
IL199914B (en) Use of protein kinase n beta to produce a diagnostic agent
CY1109695T1 (el) Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
EA200000814A1 (ru) Фармацевтическая композиция топирамата
NO972980L (no) Anvendelse av nebivolol som et anti-aterogent middel
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
MXPA03010843A (es) Uso de derivados con azetidinona en el tratamiento de enfermedad de alzheimer.
NO20015413D0 (no) Anvendelse av dopamin-D3-reseptor-ligander for fremstilling av medikamenter for behandling av nyrefunksjonsforstyrrelser
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
ATE231849T1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ATE290384T1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
MD970254A (en) Use of melatonine for treatment of patients having a medicamental dependence
SE9802836D0 (sv) Läkemedel för behandling av schizofreni
NO20014081L (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
SE9802438D0 (sv) Läkemedel för behandling av tvångstanke-tvångshandlingssjukdom
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.

Legal Events

Date Code Title Description
NUG Patent has lapsed